BlueLinx (BXC) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
16 Sep, 2026Executive summary
Net sales reached $814 million in Q2 2026, up 4.4% year-over-year, driven by specialty and structural products, with contributions from the Disdero acquisition and improved pricing.
Gross profit rose 16.7% to $140 million, with gross margin expanding 190 basis points to 17.2%, aided by tariff refunds and business transformation initiatives.
Adjusted EBITDA was $35.6 million (4.4% margin), up 33% year-over-year; excluding a $7.2 million duty-related benefit, adjusted EBITDA was $28.4 million (3.5% margin).
Adjusted net income was $9.1 million ($1.15 per diluted share), up 62% year-over-year; net income was $6.4 million ($0.81 per diluted share), up 49%.
Free cash flow improved year-over-year, reflecting stronger operating results and efficient working capital management.
Financial highlights
Specialty products accounted for 69-70% of net sales and 80-81% of gross profit, with Q2 net sales of $564 million (up 3.8-4%), gross profit of $113 million (up 12%), and gross margin of 20%.
Structural products net sales were $250 million (up 5.6-6%), gross profit $27 million (up 40%), and gross margin 10.9%.
Operating cash flow was $11 million; free cash flow was $9 million, both improved year-over-year.
Net leverage ratio was 0.6x trailing four-quarter adjusted EBITDA; cash and equivalents were $318 million, with available liquidity of $655 million.
Net debt (excluding real property leases) was $58 million.
Outlook and guidance
Specialty product gross margin expected at 18%-19% in Q3 2026, with daily sales volumes flat sequentially and higher year-over-year.
Structural product gross margin forecasted at 8.5%-9.5% in Q3, with daily volumes higher sequentially and year-over-year.
SG&A expected to average $105 million per quarter in the second half, with Q3 slightly higher than Q4.
CapEx for H2 2026 projected to be higher than prior year, supporting facility, technology, and digital initiatives.
Cautious outlook for the remainder of 2026 due to continued softness in housing conditions.
Latest events from BlueLinx
- Q1 2026 net sales up 3.1% to $731M, specialty growth, strong liquidity, and higher margins.BXC
Q1 2026 - Shareholders will vote on directors, auditor ratification, executive pay, and incentive plan changes.BXC
Proxy filing - Flat sales, specialty growth, and strong liquidity amid market headwinds and margin pressure.BXC
Q4 2025 - Director elections, auditor ratification, and executive pay are key 2025 meeting agenda items.BXC
Proxy Filing - Q2 2025 sales rose 2%, but net income and margins declined amid higher costs and price deflation.BXC
Q2 2025 - Net sales fell 7.7%-8%, but strong cash flow and liquidity supported capital returns.BXC
Q3 2024 - Q2 2024 net sales fell 5.8%-6%, but specialty margins and liquidity remained strong.BXC
Q2 2024 - Q1 2025 net sales fell 2.3% as margins compressed, but liquidity and repurchases stayed strong.BXC
Q1 2025 - 2024 net sales hit $3.0B, with strong margins, liquidity, and $45M in share repurchases.BXC
Q4 2024